# A Study Of New Medicine (GSK 372475) For The Treatment Of Depression

> **NCT00448058** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 396 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** GSK372475
- **DRUG:** venlafaxine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00448058
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 396 (ACTUAL)
- **Last updated:** 2014-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00448058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00448058, "A Study Of New Medicine (GSK 372475) For The Treatment Of Depression". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00448058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*